FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34961311000001108: Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105996901000001119 Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105997001000001115 Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Is a Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has active ingredient Olanzapine false Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has basis of strength substance Olanzapine true Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has presentation strength numerator value 5 false Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) 28 tablet 2 x 14 tablets Has AMP True Olanzapine 5mg tablets (Alissa Healthcare Research Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start